Top Stories

EMA says J&J shot can be rolled out across EU


A box of Johnson & Johnson’s Janssen COVID-19 vaccine doses are pictured at Grubb’s Pharmacy on Capitol Hill on Monday, April 12, 2021.

Tom Williams | CQ-Roll Call, Inc. | Getty Images


LONDON — The European Medicines Agency said Tuesday the Johnson & Johnson Covid-19 vaccine has possible links to rare blood clot incidents, but reiterated that its benefits still outweighed the risks.

“(The) EMA’s safety committee (PRAC) concluded that a warning about unusual blood clots with low blood platelets should be added to the product information for COVID-19 Vaccine Janssen,” the agency said in a press release.

“Healthcare professionals and people who will receive the vaccine should be aware of…


Kansas City Southern, Altria, IBM & more

Previous article

Virgin Galactic stock drops after Cathie Wood’s ARKX sale

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories